Skip to main content
. 2024 Jan 18;24:102. doi: 10.1186/s12879-023-08839-z

Table 4.

Explanatory variables for cellulitis related to characteristics of lymphoedema of the arm, by univariate analysis (n = 2160)

No cellulitis
N (%)
Cellulitis
N (%)
OR 95% CI P-value
Lymphoedema duration n = 2158
 < 1 year 485 (25.31) 30 (12.40) 1.00
 1–2 years 310 (16.18) 39 (16.12) 2.03 (1.24, 3.34)
 2–5 years 478 (24.95) 79 (32.64) 2.67 (1.72, 4.14) < 0.001
 5–10 years 378 (19.73) 67 (27.69) 2.87 (1.83, 4.50)
 > 10 years 265 (13.83) 27 (11.16) 1.65 (0.96, 2.83)
Classification of lymphoedema n = 2155
 Primary 41 (2.14) 7 (2.89) 1.00
 Secondary 1872 (97.86) 235 (97.11) 0.74 (0.33, 1.66) 0.46
Secondary lymphoedema n = 2099
 Cancer-related 1778 (95.28) 222 (95.28) 1.00
 Non-cancer-related 88 (4.72) 11 (4.72) 1.00 (0.52, 1.90) 0.99
Cancer-related secondary lymphoedema n = 1997
 Cancer treatment
  Absent 45 (2.54) 5 (2.25) 1.00
  Present 1730 (97.46) 217 (97.75) 1.13 (0.44, 2.87) 0.80
 Cancer metastatic
  Absent 1709 (96.28) 216 (97.30) 1.00
  Present 66 (3.72) 6 (2.70) 0.72 (0.31, 1.68) 0.44
Concomitant upper torso swelling
 Absent 1311 (68.35) 170 (70.25) 1.00
 Present 607 (31.65) 72 (29.75) 0.91 (0.68, 1.22) 0.55
Arm wound
 Absent 1902 (99.32) 239 (99.17) 1.00
 Present 13 (0.68) 2 (0.83) 1.22 (0.27, 5.46) 0.79
Treatment with compression n = 2159
 Absent 348 (18.16) 28 (11.59) 1.00
 Present 1568 (81.84) 214 (88.43) 1.69 (1.12, 2.56) 0.011
Control of lymphoedema n = 1841
 Not controlled 402 (24.71) 75 (35.05) 1.00
 Good control 1225 (75.29) 139 (64.95) 0.62 (0.46, 0.83) 0.001